KIMIA BIOSCIENCES
|
The Current P/E Ratio of KIMIA BIOSCIENCES is 19.73.
Share Price | ₹34.3 | Oct 14,2025 |
Market Cap | ₹162.3 Cr | |
Earnings-TTM | ₹8.2 Cr | TTM-Standalone Results |
Price/Earnings | 19.73x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of KIMIA BIOSCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹162.3 Cr] as on Oct 14,2025
(/) Earnings [ ₹8.2 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 19.73x ]
Thus, for KIMIA BIOSCIENCES , the investors are currently willing to pay 19.73 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KIMIA BIOSCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of KIMIA BIOSCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of KIMIA BIOSCIENCES
PE Ratio Performance Analysis for KIMIA BIOSCIENCES
- KIMIA BIOSCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 20.46x.
- KIMIA BIOSCIENCES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KIMIA BIOSCIENCES 's p/e ratio peaked in Mar2020 at 67.14x.
- KIMIA BIOSCIENCES 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does KIMIA BIOSCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
KIMIA BIOSCIENCES | 8.23 | 19.73 | 162.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 38.12 | 396,862.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 75.51 | 174,125.0 |
CIPLA LTD | 5,406.81 | 23.20 | 125,454.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 59.49 | 119,106.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.03 | 103,263.0 |
MANKIND PHARMA LTD | 1,905.51 | 52.77 | 100,546.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.24 | 98,525.4 |
LUPIN LTD | 3,722.18 | 23.78 | 88,506.5 |
AUROBINDO PHARMA LTD | 3,417.93 | 19.09 | 65,250.2 |
ABBOTT INDIA LTD | 1,452.29 | 44.05 | 63,967.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KIMIA BIOSCIENCES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.03x |
Max industry PE | 75.51x |
Median industry PE | 23.78x |
Average industry PE | 35.91x |
You may also like the below Video Courses